Literature DB >> 8918689

The genomic structure and chromosomal localization of the mouse STAT3 gene.

W Shi1, M Inoue, M Minami, K Takeda, M Matsumoto, Y Matsuda, T Kishimoto, S Akira.   

Abstract

A variety of cytokines induce the tyrosine phosphorylation of signal transducers and activators of transcription (STATs). Activation of the same STAT proteins by distinct cytokines and activation of different STAT proteins by each cytokine are thought to contribute to redundancy and pleiotropy of cytokine actions respectively. STAT3 is rapidly tyrosine phosphorylated in response to IL-6, ciliary neurotrophic factor, oncostatin M, leukemia inhibitory factor, IL-11, granulocyte colony stimulation factor and epidermal growth factor. In this report we have isolated and characterized the mouse genomic structure of STAT3. The mouse STAT3 gene consisted of 24 exons which spanned > 37 kb. The structure of the mouse STAT3 gene was almost identical to that of the human STAT2 gene, including the number and size of exons, indicating that the exon-intron organization had already been accomplished before these two genes duplicated, and then these genes evolved to respond to different ligands. By molecular linkage analysis with interspecific backcross mice the STAT3 gene mapped at 1.4 cM proximal to D11Mit59 on mouse chromosome 11. The promoter region contained potential regulatory elements such as GATA, NF-IL-6, PEBP2, Sp-1, AP-2 binding sites, cAMP response element, CAAT box and E-box. Transient expression of constructs harboring the 5' flanking region of the STAT3 gene fused to the luciferase gene showed that a 160 bp sequence upstream of the transcription start site conferred a basal and an IL-6-inducible promoter activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8918689     DOI: 10.1093/intimm/8.8.1205

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  8 in total

1.  Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality.

Authors:  K Takeda; K Noguchi; W Shi; T Tanaka; M Matsumoto; N Yoshida; T Kishimoto; S Akira
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

2.  Essential role of STAT3 for embryonic stem cell pluripotency.

Authors:  R Raz; C K Lee; L A Cannizzaro; P d'Eustachio; D E Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

3.  Dual role of Sp3 transcription factor as an inducer of apoptosis and a marker of tumour aggressiveness.

Authors:  Khadija Essafi-Benkhadir; Sébastien Grosso; Alexandre Puissant; Guillaume Robert; Makram Essafi; Marcel Deckert; Emmanuel Chamorey; Olivier Dassonville; Gérard Milano; Patrick Auberger; Gilles Pagès
Journal:  PLoS One       Date:  2009-02-12       Impact factor: 3.240

4.  Hyperactivated Stat3 boosts axon regeneration in the CNS.

Authors:  Saloni T Mehta; Xueting Luo; Kevin K Park; John L Bixby; Vance P Lemmon
Journal:  Exp Neurol       Date:  2016-04-06       Impact factor: 5.330

Review 5.  STAT3 in CD4+ T helper cell differentiation and inflammatory diseases.

Authors:  Charles E Egwuagu
Journal:  Cytokine       Date:  2009-08-03       Impact factor: 3.861

Review 6.  Signal transducer and activator of transcription 5A/B in prostate and breast cancers.

Authors:  Shyh-Han Tan; Marja T Nevalainen
Journal:  Endocr Relat Cancer       Date:  2008-06       Impact factor: 5.678

7.  Nuclear matrix protein SMAR1 control regulatory T-cell fate during inflammatory bowel disease (IBD).

Authors:  B Mirlekar; S Ghorai; M Khetmalas; R Bopanna; S Chattopadhyay
Journal:  Mucosal Immunol       Date:  2015-11       Impact factor: 7.313

Review 8.  IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma.

Authors:  Junnv Xu; Haifeng Lin; Gang Wu; Mingyue Zhu; Mengsen Li
Journal:  Front Oncol       Date:  2021-12-15       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.